Chen J Q, Zhang H T, Hu M H, Tang J G
National Laboratory of Protein Engineering and Plant Genetic Engineering, College of Life Sciences, Peking University, Beijing, China.
Appl Biochem Biotechnol. 1995 Oct;55(1):5-15. doi: 10.1007/BF02788744.
The construction of a gene encoding Lys-human proinsulin, its direct expression in E. coli, and the simple purification procedure are described here. The temperature inducible promotor was employed for induction in a very short time. The expression level could reach 20-30%. After simple downstream processing and only one step of Sephadex G50 purification, 150 mg recombinant Lys-human proinsulin with a purity of up to 90% could be obtained easily from 1 L of high density fermentation medium. The obtained product is in the form of Met-Lys-human proinsulin because of the failure of the bacterial host to remove the initiator methionine residue. The Lys-human proinsulin could be changed into human insulin by trypsin and carboxypeptidase B treatment in later steps. After separation with DEAE-Sephadex A25, human insulin with expected amino acid composition and full native biological activity could be obtained with a yield of 50 mg/L of fermentation medium.
本文描述了编码赖氨酸-人胰岛素原的基因构建、其在大肠杆菌中的直接表达以及简单的纯化过程。采用温度诱导启动子在极短时间内进行诱导。表达水平可达20% - 30%。经过简单的下游处理和仅一步葡聚糖凝胶G50纯化后,可轻松从1升高密度发酵培养基中获得150毫克纯度高达90%的重组赖氨酸-人胰岛素原。由于细菌宿主无法去除起始甲硫氨酸残基,所得产物为甲硫氨酸-赖氨酸-人胰岛素原形式。后续步骤中,通过胰蛋白酶和羧肽酶B处理,赖氨酸-人胰岛素原可转化为人胰岛素。用DEAE - 葡聚糖凝胶A25分离后,可获得具有预期氨基酸组成和完全天然生物活性的人胰岛素,产量为每升发酵培养基50毫克。